Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: back pain

Rheumatology Education Reboot: Fresh, Interactive Session Formats at the 2019 ACR/ARP Annual Meeting

From the College  |  July 23, 2019

The ACR is known for excellence in rheumatology education—and 2019 will be no exception. This year’s annual meeting offers innovative session formats and user-friendly, interactive approaches to learning…

Filed under:Education & Training Tagged with:2019 ACR/ARP Annual MeetingEducation

Addiction Therapy Is Underprescribed but May Benefit Medical Adherence

Thomas R. Collins  |  July 18, 2019

CHICAGO—Although medical treatments for addiction have been proved effective, they are not used often enough, said Kenneth Stoller, MD, during a session at the 2019 ACR State-of-the-Art Clinical Symposium, held April 5–7. These treatments bring health benefits that extend beyond addiction, he said. Dr. Stoller, assistant professor of psychiatry and behavioral sciences at Johns Hopkins…

Filed under:Conditions Tagged with:Addictionaddiction treatmentadherence

How Rheumatologists Can Better Partner with Social Workers

Linda Childers  |  July 18, 2019

When Liz Morasso, LCSW, facilitates a Families Living with Rheumatic Diseases support group at Children’s Hospital Los Angeles, she empathizes with the struggles and challenges of her young patients. Ms. Morasso was only 16 years old when she was diagnosed with both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). She knows all too well…

Filed under:Patient PerspectivePractice Support Tagged with:Association of Rheumatology Professionals (ARP)interdisciplinarysocial worker

This CT scan demonstrates a mass causing partial occlusion of the esophagus.

Case Report: An Adult-Onset Still’s Disease Mimic

Theodore Korty, DO, Ken Baxa, DO, Kiren Sahni, DO, Adam Grunbaum, DO, & Maria Soto-Aguilar, MD  |  July 18, 2019

A 53-year-old man was hospitalized for pericarditis, abdominal lymphadenopathy of unknown origin and non-bloody diarrhea. He was admitted for four days, and then he was discharged home without incident. Two months after his initial presentation, he was readmitted for the evaluation of several new issues, including symmetric arthralgias, hypovolemia with associated electrolyte abnormalities and concurrent…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:adenocarcinomaadult Still's DiseasearthralgiasCancerlymphomaparaneoplastic syndrome

David M. Phillips / Science Source

Lyme Arthritis: Presentation, Diagnosis & Treatment

John N. Aucott, MD, & Sheila L. Arvikar, MD  |  July 18, 2019

A 52-year-old man living in greater Boston with a history of hyper­tension presented at our rheumatology clinic with bilateral knee pain and swelling. He had been in his usual state of health until four months earlier when he developed right knee pain and swelling without an incipient trauma, which did not improve with non-steroidal anti-inflammatory…

Filed under:Conditions Tagged with:Borrelia burgdorferiLyme arthritisLyme Disease

Exercise Therapy Benefits Patients with Knee & Hip OA

Lara C. Pullen, PhD  |  July 18, 2019

A meta-analysis confirms prior research suggesting exercise therapy benefits patients with knee and hip osteoarthritis (OA). The study found greater improvements in pain, function, performance and quality of life in patients with milder, as opposed to more severe, OA…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:ExerciseExercise/physical therapyhipkneeKnee Osteoarthritis (OA)osteoarthritis (OA)

Opioids Commonly Prescribed for Gout Attacks

Reuters Staff  |  July 9, 2019

NEW YORK (Reuters Health)—Nearly three in 10 patients seeking care at the emergency department (ED) for acute gout will be discharged with a prescription for opioids, new research shows. “Our study suggests a high use of prescription opioid in patients discharged from the ED with a diagnosis of gout, a condition that can be managed…

Filed under:ConditionsGout and Crystalline ArthritisResearch Rheum Tagged with:Arthritis Care & ResearchEmergency DepartmentGoutopioidPainPain Management

Ankylosing Spondylitis Patients Report Improved Quality of Life with Bimekizumab

Michele B. Kaufman, PharmD, BCGP  |  July 8, 2019

Recent research shows bimekizumab may improve patient-reported outcomes and quality of life for ankylosing spondylitis (AS) patients…

Filed under:Axial SpondyloarthritisDrug UpdatesEULAR/OtherMeeting Reports Tagged with:Ankylosing SpondylitisBimekizumabEULAR

Tanezumab’s Phase 3 Results for OA

Michele B. Kaufman, PharmD, BCGP  |  June 25, 2019

In a recent study, tanezumab proved safe and effective in the treatment of knee and hip osteoarthritis…

Filed under:AnalgesicsDrug Updates Tagged with:hipkneeKnee Osteoarthritis (OA)osteoarthritis (OA)Paintanezumab

The Rescue: Moving RA Patients from Adalimumab to Baricitinib

Lara C. Pullen, PhD  |  June 25, 2019

The phase 3, RA-BEAM study found RA patients who were switched from adalimumab to baricitinib experienced improvements in disease control even in the absence of an adalimumab washout. In the study, the change was not associated with an increase in adverse events or infections…

Filed under:ConditionsRheumatoid Arthritis Tagged with:adalimumabbaricitinibRheumatoid Arthritis (RA)washout

  • « Previous Page
  • 1
  • …
  • 81
  • 82
  • 83
  • 84
  • 85
  • …
  • 162
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences